Latest News and Press Releases

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025

April 11, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2024 Biodexa...

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates

CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy

CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates